Maurizia Rossana Brunetto

Author

Azienda Ospedaliera Universitaria Pisana ORCID

Also Known As

BRUNETTO, MAURIZIA ROSSANA, Brunetto, Brunetto, M, Brunetto, Maurizia R., Giuseppina Brancaccio, Luigi Muratori, M BRUNETTO, M Brunetto, M R Brunetto, M. A. Brunetto

776

Publications

22.2K

Citations

H-Index

182

Concepts

All Affiliations

Azienda Ospedaliera Universitaria Pisana University of Pisa Fondazione Ricerca Molinette University of Padua University of Milan

About

Maurizia Rossana Brunetto is an author at Azienda Ospedaliera Universitaria Pisana specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	116	10.4K
2	Health Sciences	11	12	921
3	Engineering	9	9	246
4	Natural Sciences	4	4	108
5	Education	1	1	41

Maurizia Rossana Brunetto

220

Publications

16.4K

Citations

H-Index

Page 1

	Year	Citations
Statements from the Taormina expert meeting on occult hepatitis B virus infection Giovanni Raimondo, Jean‐Pierre Allain, Maurizia Rossana Brunetto, Journal of Hepatology Viral HepatitisHepatitis BHepatitisVirologyTaormina Expert Meeting	2008	816
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases B. Coco, Filippo Oliveri, A.M. Maina, Journal of Viral Hepatitis	2006	652
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan, The Lancet. Gastroenterology & hepatology HepatologyViral HepatitisHepatitis BHepatitisAntiviral Therapy	2016	535
Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # † Maurizia Rossana Brunetto, F. Moriconi, Ferruccio Bonino, Hepatology	2008	481
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage Claire Dunn, Maurizia Rossana Brunetto, Gary Reynolds, The Journal of Experimental Medicine	2007	415
Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers Maurizia Rossana Brunetto, Filippo Oliveri, P. Colombatto, Gastroenterology Hepatitis DHepatologyViral HepatitisImmunologyHepatitis B	2010	409
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto, Journal of Hepatology HepatologyViral HepatitisPharmacologyHepatitis BHepatitis	2018	406
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis Xiangdong Liu, Pietro Invernizzi, Yue Lu, Nature Genetics Genome-wide Association StudyHepatologyBiliary TractBiliary CancerGenetics	2010	395
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Maurizia Rossana Brunetto, M. Giarin, Filippo Oliveri, Proceedings of the National Academy of Sciences Hepatitis DDiagnostic VirologyViral PersistenceHepatologyOligonucleotide Hybridization Assay	1991	383

Page 1